Republished Education in Heart: New P2Y12 inhibitors

被引:0
|
作者
Storey, Robert F. [1 ]
机构
[1] Univ Sheffield, Dept Cardiovasc Sci, Sheffield S10 2RX, S Yorkshire, England
关键词
ACUTE CORONARY SYNDROMES; OUTCOMES PLATO TRIAL; PLATELET INHIBITION; RECEPTOR ANTAGONIST; DOSE CLOPIDOGREL; TICAGRELOR; INTERVENTION; PRASUGREL; TOLERABILITY; SAFETY;
D O I
10.1136/pgmj.2009.184242rep
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:49 / 54
页数:6
相关论文
共 50 条
  • [41] Can new generation P2Y12 inhibitors play a role in microvascular obstruction in STEMI?
    Vannini, Luca
    Muro, Anna
    Sanchis, Juan
    Ortiz-Perez, Jose T.
    Flores Umanzor, Eduardo
    Pilar Lopez-Lereu, Maria
    Badimon, Lina
    Sabate, Manel
    Brugaletta, Salvatore
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 223 : 226 - 227
  • [42] Mode of action of P2Y12 antagonists as inhibitors of platelet function
    Glenn, J.
    Iyu, D. E.
    White, A. E.
    Fox, S. C.
    van Giezen, H.
    Nylander, S.
    Heptinstall, S.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 319 - 320
  • [43] Drug Interaction: Opioids and Oral P2Y12 Platelet Inhibitors
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1566): : 31 - 32
  • [44] Mode of action of P2Y12 antagonists as inhibitors of platelet function
    Iyu, David
    Glenn, Jackie R.
    White, Ann E.
    Fox, Sue C.
    van Giezen, Hans
    Nylander, Sven
    Heptinstall, Stan
    THROMBOSIS AND HAEMOSTASIS, 2011, 105 (01) : 96 - 106
  • [45] Thienopyrimidine-based P2Y12 platelet aggregation inhibitors
    Kortum, Steven W.
    Lachance, Rhonda M.
    Schweitzer, Barbara A.
    Yalamanchili, Gopichand
    Rahman, Hayat
    Ennis, Michael D.
    Huff, Rita M.
    TenBrink, Ruth E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (20) : 5919 - 5923
  • [46] Choice of P2Y12 Inhibitors After Acute Coronary Syndrome
    Ando, Giuseppe
    Gragnano, Felice
    Pelliccia, Francesco
    Calabro, Paolo
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 211 : 377 - 377
  • [47] Looking into the future of platelet transfusion in the presence of P2Y12 inhibitors
    Tanaka, K. A.
    Subramaniam, K.
    BRITISH JOURNAL OF ANAESTHESIA, 2014, 112 (05) : 780 - 784
  • [48] P2Y12 inhibitors in acute coronary syndromes: Which and when?
    Pais, Prem
    NATIONAL MEDICAL JOURNAL OF INDIA, 2013, 26 (02): : 84 - 90
  • [49] The need to identify new P2Y12 receptor inhibitors in the management and prevention of arterial thrombosis
    Serra, Raffaele
    de Franciscis, Stefano
    THROMBOSIS RESEARCH, 2014, 134 (03) : 533 - 534
  • [50] Should P2Y12 inhibitors be given for 12 months in acute coronary syndrome?
    Christodoulidis, Georgios
    Baber, Usman
    Mehran, Roxana
    CURRENT OPINION IN CARDIOLOGY, 2014, 29 (04) : 301 - 306